{"id":"NCT01971645","sponsor":"Nationwide Children's Hospital","briefTitle":"Decadron as Adjuvant in Femoral Nerve Blocks in Knee Arthroscopy","officialTitle":"Dexamethasone as an Adjuvant to Ropivacaine for Femoral Nerve Blocks in Children Undergoing Knee Arthroscopy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-07","primaryCompletion":"2016-07","completion":"2016-09","firstPosted":"2013-10-29","resultsPosted":"2018-03-20","lastUpdate":"2018-12-11"},"enrollment":77,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Knee Injury"],"interventions":[{"type":"DRUG","name":"Dexamethasone","otherNames":[]},{"type":"DRUG","name":"Ropivacaine","otherNames":[]}],"arms":[{"label":"Group D","type":"EXPERIMENTAL"},{"label":"Group R","type":"PLACEBO_COMPARATOR"},{"label":"Group M","type":"ACTIVE_COMPARATOR"}],"summary":"If preservative-free dexamethasone 0.1 mg/kg (max dose 4 mg) is added to ropivacaine 0.5% 2 mg/kg (max dose 100 mg), then post-PACU opioid consumption will be reduced by 33%.","primaryOutcome":{"measure":"Intra-operative and Post-operative Opioid Consumption","timeFrame":"Intra-operative and up to 48 hours post-discharge, an average of 48 hours","effectByArm":[{"arm":"Group D","deltaMin":2,"sd":null},{"arm":"Group R","deltaMin":2,"sd":null},{"arm":"Group M","deltaMin":3,"sd":null}],"pValues":[]},"eligibility":{"minAge":"10 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":13},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["29377866"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":25},"commonTop":["emergence delerium"]}}